Table 3 ExAblate treatments in 2003–2011
Year | Mean age, years (SD) | Mean BMI (SD) | Mean SSS (SD) | Mean uterine volume, ml (SD) | Mean total fibroid volume, ml (SD) | Mean %NPV (SD) | % HI dominant fibroid |
|---|---|---|---|---|---|---|---|
2003 | 41.97 (5.44) | 24.95 (4.05) | 64.79 (17.47) | 809.73 (445.48) | 333.8 (209.75) | 41.22 (25.66) | 29.2 |
2004 | 43.87 (5.09) | 24.11 (3.17) | 62.1 (14.05) | 734.20 (323.86) | 387.0 (198.31) | 47.33 (23.21) | 29.0 |
2005 | 43.67 (8.93) | 27.23 (4.14) | 78.12 (16.24) | 949.51 (383.33) | 544.23 (276.52) | 33.4 (20.34) | 30.8 |
2006 | 42.74 (10.20) | 25.00 (4.39) | 64.1 (19.13) | 958.1 (469.46) | 495.1 (291.49) | 39.4 (24.31) | 26.9 |
2007 | 42.25 (5.93) | 26.10 (5.55) | 59.4 (16.93) | 828.65 (446.98) | 431.7 (289.64) | 40.7 (22.04) | 32.0 |
2008 | 43.15 (6.97) | 23.75 (3.08) | 64.1 (19.26) | 861.90 (469.25) | 445.1 (314.95) | 44.54 (21.10) | 36.4 |
2009 | 41.1 (6.00) | 25.37 (5.97) | 57.9 (19.04) | 611.01 (249.98)*a | 314.3 (195.75) | 51.53 (19.63) | 25.92 |
2010 | 40.4 (7.67) | 25.5 (4.00) | 65.46 (19.18) | 658.38 (296.37)**a | 319.2 (241.88) | 50.49 (18.23) | 13.78*****b |
2011 (ExAblate 2100) | 39.47 (6.53) | 23.41 (4.25) | 61.02 (17.13) | 655.06 (257.49)***a | 305.12 (203.43) | 54.78 (19.01)****a | 17.1 |